Citation Impact
Citing Papers
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency
2008 StandoutScienceNobel
The Genotoxic Effects in Lymphocyte Cultures of Children Treated with Radiosynovectomy by Using Yttrium-90 Citrate Colloid
2007
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
2010
The global burden of gout: estimates from the Global Burden of Disease 2010 study
2014
Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares
2015
Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease
2007
Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan
2013
Re-establishing immunological self-tolerance in autoimmune disease
2012 StandoutNobel
Does This Adult Patient Have Septic Arthritis?
2007
An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population
2015
Gout and hyperuricemia
2002
Systemic Sclerosis
2002
Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study
2012
PTPN22: the archetypal non-HLA autoimmunity gene
2014
The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012
2016
The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study
2014 Standout
Twenty-eight loci that influence serum urate levels: analysis of association with gout
2014
Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies
2017
The T-box factor MLS-1 acts as a molecular switch during specification of nonstriated muscle in C. elegans
2002 StandoutNobel
Intimate partner violence: causes and prevention
2002 Standout
Allopurinol hypersensitivity: investigating the cause and minimizing the risk
2015
Clinical and Genetic Features of Ehlers–Danlos Syndrome Type IV, the Vascular Type
2000 Standout
Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout
2015
Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial
2012
Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
2012
“What say ye gout experts?” a content analysis of questions about gout posted on the social news website Reddit
2017
Hyperuricaemia and gout: time for a new staging system?
2014
Juvenile idiopathic arthritis
2007 Standout
Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels
1997
Gout: why is this curable disease so seldom cured?
2012
Vitamin D Deficiency
2007 Standout
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes
2009 Standout
Health-related quality of life in gout: a systematic review
2013
Systemic sclerosis
2017 Standout
Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study
2014
Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna
2004
Gout
2009 Standout
Scleroderma
2009 Standout
Ethnicity and race and systemic sclerosis: How it affects susceptibility, severity, antibody genetics, and clinical manifestations
2003
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
2014
Structural Basis for Recognizing Phosphoarginine and Evolving Residue-Specific Protein Phosphatases in Gram-Positive Bacteria
2013 StandoutNobel
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol
2008
Progressive systemic sclerosis: Mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients
1988
Interstitial Lung Disease in Systemic Sclerosis
2008 Standout
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
The unclosing premature mortality gap in gout: a general population-based study
2017
The Association of Registered Nurse Staffing Levels and Patient Outcomes
2007 Standout
Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study
2012
The genetics of hyperuricaemia and gout
2012
Ankylosing spondylitis
2007 Standout
Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients
2001
Gout
2016 Standout
Hyperuricaemia in the Pacific: why the elevated serum urate levels?
2013
Shared and Distinct Genetic Variants in Type 1 Diabetes and Celiac Disease
2008
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Juvenile chronic arthritis in India: is it different from that seen in Western countries?
1994
Gout in Solid Organ Transplantation
2005
Magnetic Resonance Imaging Bone Edema Is Not a Major Feature of Gout Unless There Is Concomitant Osteomyelitis: 10-year Findings from a High-prevalence Population
2011
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol
2012
The outcome of ankylosing spondylitis: a study of 100 patients.
1997
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Potential Contribution of Cytochrome P450 2B6 to Hepatic 4-Hydroxycyclophosphamide Formation In Vitro and In Vivo
2011
Major Depressive Disorder
2008 Standout
Saturation in qualitative research: exploring its conceptualization and operationalization
2017 Standout
The Body That Knows: From Cashinahua Epistemology to a Medical Anthropology of Lowland South America
1996
Isolation and Characterization of a Gene from the DiGeorge Chromosomal Region Homologous to the MouseTbx1Gene
1997
Role of PTPN22 in type 1 diabetes and other autoimmune diseases
2006
Gout
2003
Risk factors for gout and prevention: a systematic review of the literature
2011
Systematic review of the prevalence of gout and hyperuricaemia in Australia
2012
British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout
2007
Anemia of inflammation: the hepcidin link
2005
Determinants of the prevalence of gout in the general population: a systematic review and meta-regression
2014
Regulation of type I interferon responses
2013 Standout
Familial risk estimation in systemic sclerosis
1999
Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function
2013
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
2005 Standout
Sex differences in immune responses
2016 Standout
Participation of the TRPV1 receptor in the development of acute gout attacks
2013
The experience and impact of gout in Māori and Pacific people: a prospective observational study
2012
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
PTPN22: Setting thresholds for autoimmunity
2006
Solitary retinal capillary hemangioma: Lack of genetic evidence for von Hippel-Lindau disease
2002
Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts
2018
Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load
2013
Sugar consumption, metabolic disease and obesity: The state of the controversy
2015
Genetic predisposition to autoimmunity – What have we learned?
2011
Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States
1997 Standout
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
2007
Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
2013
Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial
2016
Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment
2010
Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20)
2014
CARDIAC INVOLVEMENT IN SCLERODERMA
1996
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout
2017
Global epidemiology of gout: prevalence, incidence and risk factors
2015 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?
2011
Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation
2004 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Piezo1 links mechanical forces to red blood cell volume
2015 StandoutNobel
Derivation and External Validation of a Prediction Rule for Five‐Year Mortality in Patients With Early Diffuse Cutaneous Systemic Sclerosis
2015
Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies
2018
Tyrosine Phosphatase PTPN22: Multifunctional Regulator of Immune Signaling, Development, and Disease
2013
Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study.
2007
The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool
2018
B7x in the Periphery Abrogates Pancreas-Specific Damage Mediated by Self-reactive CD8 T Cells
2012 StandoutNobel
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation
2019 StandoutNobel
Predicting allopurinol response in patients with gout
2015
Loss of the Protein Tyrosine Phosphatase PTPN22 Reduces Mannan-Induced Autoimmune Arthritis in SKG Mice
2016 StandoutNobel
Depression and Coronary Heart Disease
2008 Standout
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
AnFgf8mouse mutant phenocopies human 22q11 deletion syndrome
2002 StandoutNobel
Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis
2002
Derivation and Validation of a Prediction Rule for Two‐Year Mortality in Early Diffuse Cutaneous Systemic Sclerosis
2014
Comprehensive dietary education in treated gout patients does not further improve serum urate
2014
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+channel,IKCa1: A potential immunosuppressant
2000
The Molecular Physiology of Uric Acid Homeostasis
2014
Health-related quality of life in ankylosing spondylitis: A survey of 175 patients
1999
Gout
2021 Standout
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
NPT1/SLC17A1 Is a Renal Urate Exporter in Humans and Its Common Gain‐of‐Function Variant Decreases the Risk of Renal Underexcretion Gout
2014
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
2004 Standout
Lowering serum uric acid levels: What is the optimal target for improving clinical outcomes in gout?
2007
Graded Attenuation of TCR Signaling Elicits Distinct Autoimmune Diseases by Altering Thymic T Cell Selection and Regulatory T Cell Function
2010 StandoutNobel
Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders
2005
Contesting modernity: Tobacco use and romanticism among older Dai farmers in Xishuangbanna, China
2015
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28‐week, phase III, randomized, double‐blind, parallel‐group trial
2008
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Gout Self‐Management in African American Veterans: A Qualitative Exploration of Challenges and Solutions From Patients' Perspectives
2017
Cosmological Deixis and Amerindian Perspectivism
1998 Standout
Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs
2010 Standout
Works of Peter Gow being referenced
Facilitating equitable prevention and management of gout for Māori in Northland, New Zealand, through a collaborative primary care approach
2019
Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout
2013
Potential unmet need for gout diagnosis and treatment: capture-recapture analysis of a national administrative dataset
2012
The combined impact ofCYP2C19andCYP2B6pharmacogenetics on cyclophosphamide bioactivation
2010
Factors Associated With Recurrent Hospital Admissions for Gout
2009
Three new point mutations in type II procollagen (COL2A1) and identification of a fourth family with the COL2A1 Arg519→Cys base substitution using conformation sensitive gel electrophoresis
1995
Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case–control sample sets
2009
The PTPN22 Locus and Rheumatoid Arthritis: No Evidence for an Effect on Risk Independent of Arg620Trp
2010
Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study
2013
National prevalence of gout derived from administrative health data in Aotearoa New Zealand
2012
Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis
2007
A homozygous HAMP mutation in a multiply consanguineous family with pseudo‐dominant juvenile hemochromatosis
2004
A qualitative study to explore health professionals’ experience of treating gout: understanding perceived barriers to effective gout management
2016
JUVENILE RHEUMATOID ARTHRITIS IN AUCKLAND: A LONG TERM FOLLOW‐UP STUDY WITH PARTICULAR REFERENCE TO UVEITIS
1987
Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort
2005
A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets
2010
Towards excellence in quality patient care: A clinical pathway for myocardial infarction
1999
The renal urate transporter SLC17A1 locus: confirmation of association with gout
2012
Efficacy and Tolerability of Probenecid as Urate-lowering Therapy in Gout; Clinical Experience in High-prevalence Population
2013
The Experience and Impact of Living With Gout
2011
The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity
2011
Synovial fluid lactic acid in septic arthritis.
1981
Sex and Violence: Issues in Representation and Experience.
1996
A survey of current prescribing practices of antiinflammatory and urate-lowering drugs in gouty arthritis.
1991
Debunking the myths to provide 21st Century management of gout.
2008
Employment in ankylosing spondylitis.
1984
Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice.
2012
A CLINICAL AND PROSPECTIVE CHROMOSOMAL STUDY OF YTTRIUM-90 SYNOVECTOMY
1977
The Perverse Child: Desire in a Native Amazonian Subsistence Economy
1989
Variation in gout care in Aotearoa New Zealand: a national analysis of quality markers.
2014
A survey of indications, results and complications of surgery for tophaceous gout.
2002
Tobacco and Shamanism in South America
1989
Progressive Systemic Sclerosis in Auckland: A Ten Year Review with Emphasis on Prognostic Features
1981
The optimal use of allopurinol: an audit of allopurinol use in South Auckland
2000
Benzbromarone therapy in management of refractory gout.
2005
Clotrimazole in rheumatoid arthritis.
1980
Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
2006